CGC Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Sell
202
-23
-10% -$11K 0.02% 102
2026
Q1
$111K Hold
225
0.03% 89
2025
Q4
$130K Sell
225
-15
-6% -$8.48K 0.03% 85
2025
Q3
$116K Hold
240
0.03% 84
2025
Q2
$97.3K Hold
240
0.03% 91
2025
Q1
$119K Hold
240
0.05% 71
2024
Q4
$125K Hold
240
0.05% 69
2024
Q3
$148K Hold
240
0.06% 61
2024
Q2
$133K Hold
240
0.06% 62
2024
Q1
$139K Sell
240
-181
-43% -$102K 0.07% 60
2023
Q4
$223K Buy
421
+60
+17% +$29K 0.1% 52
2023
Q3
$183K Hold
361
0.13% 44
2023
Q2
$188K Buy
+361
New +$195K 0.12% 46

Other funds holding TMO

CGC Financial Services's TMO Position: Q2 2026 in Review

CGC Financial Services reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $11K and leaving 202 shares worth $101K. The position accounts for 0.02% of the portfolio, ranked #102.

CGC Financial Services first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $223K in Q4 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CGC Financial Services held 202 shares of Thermo Fisher Scientific worth $101K as of Q2 2026.
  • CGC Financial Services sold 23 Thermo Fisher Scientific shares in Q2 2026, an estimated $11K.
  • Thermo Fisher Scientific made up 0.02% of CGC Financial Services's portfolio in Q2 2026, its #102 holding.
  • CGC Financial Services first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • CGC Financial Services's Thermo Fisher Scientific position peaked at $223K in Q4 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.